August 30, 2013

Last month, the SDBC reported that it was conducting an experiment in collaboration with UCSD radiology department to test the integrity of the Blood-Brain-Barrier...

August 1, 2013

1. First in BBB Patents:  On July 11, 2013 the United States Patent and Trademark Office published the FIRST AND ONLY patent entitled Blood-Brain-Barrier...

July 2, 2013

Making it work on less than optimal funding, the SDBC continues to astonish the world with results and scientific experiments they carry out on...

June 29, 2013

Have you heard of Prozac®, Cymbalta®, Aricept®, Imitrex® or Paxel®? Maybe you take one of them. These are just a few of the medications...

June 3, 2013

The month of May was a very busy month for the SDBC in that we moved our vivarium to our new facility. Our efforts in...

May 1, 2013

We are happy to be in our new office and laboratory space continuing on our mission “Road to the Cure.” For a better understanding...

March 29, 2013

Have you heard of Prozac®, Cymbalta®, Aricept®, Imitrex® or Paxel®? Maybe you take one of them. These are just a few medications that California...

March 4, 2013

The momentum in the SDBC’s Road to the Cure continues to accelerate. The interest of world renowned scientists and perhaps the world’s largest Parkinson’s...

February 1, 2013

We are even more encouraged by the activities at the SDBC with the production buildup for attacking the Parkinson’s protein of LRRK2. In the...

December 29, 2012

The management of the San Diego Biotech Company (SDBC) has every reason to thank God for His grace and its investors whose financial contributions...

December 1, 2012

This month, the San Diego Biotech Company (SDBC) received some additional data from their collaborator, Dr. E. Masliah, UCSD Department of Neurosciences. This data...

November 27, 2012

The San Diego Biotech Company (SDBC) is continuing its efforts to speed up the development of diagnostics and therapeutics for Parkinson’s disease. 1. Dr. Anna...

October 3, 2012

Watching the science on the ROAD TO CURE PARKINSON’S, in order to excel the development of diagnostics and therapeutics for Parkinson’s disease, the San...

September 1, 2012

The failure of a recent large clinical trial of one of the Alzheimer’s drugs, Bapineuzumab, undertaken by pharmaceutical giants Johnson and Johnson, Pfizer and...

August 18, 2012

The biotech company in San Diego, in collaboration with Dr. Masliah of UCSD, had commenced the Blood-Brain Barrier study with its a-synuclein-picobody in Parkinson’s-like...